These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2095402)

  • 1. Pharmacokinetics and enterohepatic circulation of (E)-2-ene valproic acid in the rat.
    Singh K; Orr JM; Abbott FS
    J Pharmacobiodyn; 1990 Oct; 13(10):622-7. PubMed ID: 2095402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and enterohepatic circulation of 2-n-propyl-4-pentenoic acid in the rat.
    Singh K; Orr JM; Abbott FS
    Drug Metab Dispos; 1988; 16(6):848-52. PubMed ID: 2907464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative investigation of 2-propyl-4-pentenoic acid (4-ene VPA) and its alpha-fluorinated analogue: phase II metabolism and pharmacokinetics.
    Tang W; Abbott FS
    Drug Metab Dispos; 1997 Feb; 25(2):219-27. PubMed ID: 9029053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonlinear elimination and cholerteic effect of valproic acid in the monkey.
    Dickinson RG; Taylor SM; Kaufman SN; Rodgers RM; Lynn RK; Gerber N; Baughman WL
    J Pharmacol Exp Ther; 1980 Apr; 213(1):38-48. PubMed ID: 6767022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choleretic effect of valproic acid in the rat.
    Watkins JB; Klaassen CD
    Hepatology; 1981; 1(4):341-7. PubMed ID: 6793496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of teratogenicity of trans-2-ene-valproic acid compared to valproic acid in rats.
    Vorhees CV; Acuff-Smith KD; Weisenburger WP; Minck DR; Berry JS; Setchell KD; Nau H
    Teratology; 1991 Jun; 43(6):583-90. PubMed ID: 1882349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capillary GCMS assay of 2-n-propyl-4-pentenoic acid (4-ene VPA) in rat plasma and urine.
    Singh K; Abbott FS; Orr JM
    Res Commun Chem Pathol Pharmacol; 1987 May; 56(2):211-23. PubMed ID: 3602586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of valproic acid in the rat: dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect.
    Dickinson RG; Harland RC; Ilias AM; Rodgers RM; Kaufman SN; Lynn RK; Gerber N
    J Pharmacol Exp Ther; 1979 Dec; 211(3):583-95. PubMed ID: 390116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abolition of valproate-derived choleresis in the Mrp2 transporter-deficient rat.
    Wright AW; Dickinson RG
    J Pharmacol Exp Ther; 2004 Aug; 310(2):584-8. PubMed ID: 15075379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans.
    Kassahun K; Farrell K; Abbott F
    Drug Metab Dispos; 1991; 19(2):525-35. PubMed ID: 1676665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of valproate analogs in rats. III. Pharmacokinetics of valproic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid in the bile-exteriorized rat.
    Liu MJ; Brouwer KL; Pollack GM
    Drug Metab Dispos; 1992; 20(6):810-5. PubMed ID: 1362931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans-2-ene-valproic acid is less behaviorally teratogenic than an equivalent dose of valproic acid in rats.
    Fisher JE; Acuff-Smith KD; Schilling MA; Nau H; Vorhees CV
    Teratology; 1994 Jun; 49(6):479-86. PubMed ID: 7747269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of thiol-conjugated metabolites of 2-propylpent-4-enoic acid (4-ene VPA), a toxic metabolite of valproic acid, by electrospray tandem mass spectrometry.
    Tang W; Abbott FS
    J Mass Spectrom; 1996 Aug; 31(8):926-36. PubMed ID: 8799319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile-salt-dependent and independent choleresis induced by bucolome in the rat.
    Kitani K; Morita Y; Miura R; Kanai S
    Can J Physiol Pharmacol; 1977 Oct; 55(5):1155-61. PubMed ID: 21733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption and enterohepatic circulation of baicalin in rats.
    Xing J; Chen X; Zhong D
    Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between glucuronide conjugate levels and hepatotoxicity after oral administration of valproic acid.
    Lee MS; Lee YJ; Kim BJ; Shin KJ; Chung BC; Baek DJ; Jung BH
    Arch Pharm Res; 2009 Jul; 32(7):1029-35. PubMed ID: 19641884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo formation of the thiol conjugates of reactive metabolites of 4-ene VPA and its analog 4-pentenoic acid.
    Kassahun K; Abbott F
    Drug Metab Dispos; 1993; 21(6):1098-106. PubMed ID: 7905390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacodynamics and brain distribution of E-delta 2-valproate and valproate in rats.
    Semmes RL; Shen DD
    Epilepsia; 1991; 32(2):232-41. PubMed ID: 2004628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enterohepatic circulation in rat and dog of 14C-0-[3-(4-less than 2-methoxyphenyl greater than-1-piperazinyl)-2-hydroxypropyl]-3-methoxy-benzaldoxim dihydrochloride and it's demethylated metabolite.
    Paul H; Illing A; House ES
    Eur J Drug Metab Pharmacokinet; 1981; 6(4):303-12. PubMed ID: 7333331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enterohepatic circulation of triiodothyronine (T3) in rats: importance of the microflora for the liberation and reabsorption of T3 from biliary T3 conjugates.
    Rutgers M; Heusdens FA; Bonthuis F; de Herder WW; Hazenberg MP; Visser TJ
    Endocrinology; 1989 Dec; 125(6):2822-30. PubMed ID: 2583041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.